Stocktoria
Processa Pharmaceuticals, Inc. PCSA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2013-10-07
Processa Pharmaceuticals, Inc. statistics & valuation
Market cap$5.1M
P / B0.9×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -173.6% | -367.0% | -192.2% | -318.2% | -43.2% |
| Return on equity | -243.2% | -698.6% | -222.9% | -367.1% | -44.8% |
| Current ratio | 2.54 | 1.23 | 7.71 | 8.40 | 18.87 |
Source: SEC EDGAR filings · CIK 0001533743 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.